SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is surging following a blowout earnings report that shattered analyst expectations for both revenue and profitability, driven by massive growth in U.S. commercial adoption and strengthened guidance. While the community is actively celebrating the stock's resilience, discussions remain polarized between investors highlighting Palantir's leadership in sovereign AI and skeptics continuing to debate the company's valuation and long-term sustainability.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is seeing intense volatility and negative sentiment following a major debt exchange that will result in shareholder dilution. Community members are divided, with many debating the strategic necessity of the move for potential future acquisitions versus frustration over continued share issuance.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending as investor focus intensifies ahead of upcoming quarterly earnings, with the community actively debating whether the company's advertising recovery and AI-powered subscription growth signal a long-awaited turnaround. While some bulls are encouraged by improving profitability and speculation regarding potential buyouts or strategic partnerships, skeptics remain cautious due to historical user growth challenges and the uncertain market reception of the company's augmented reality hardware.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as market participants focus on strong revenue growth from its core multiple sclerosis drug, Briumvi, and anticipation surrounding its upcoming subcutaneous launch and pipeline expansion. Despite some short-term volatility and analyst-driven EPS misses, the community remains heavily bullish, citing consistent guidance raises and persistent acquisition rumors as primary drivers for long-term value.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is experiencing intense volatility as traders weigh reports of renewed military escalations in the Middle East against persistent, market-moving claims from the White House regarding imminent peace deals. Investors are closely monitoring the Strait of Hormuz for potential supply disruptions, while the broader community remains deeply divided over the reliability of diplomatic announcements versus the reality of depleted strategic reserves.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is under significant scrutiny as investors grapple with a bearish multi-month downtrend and growing concerns regarding consumer spending habits and menu affordability. While some investors identify the stock's multi-year low valuation as a potential long-term accumulation opportunity, community sentiment remains sharply divided between those betting on a turnaround and others who are aggressively shorting the stock, citing perceived weaknesses in the brand's competitive position and recent food quality narratives.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors aggressively position themselves ahead of the upcoming earnings report, with community sentiment split between expectations of a significant beat driven by AI infrastructure demand and fears of a potential pullback due to elevated valuations. Discussions are heavily focused on the stock's volatility and the influence of institutional positioning, as traders debate whether current momentum will lead to a breakout or if the stock is vulnerable to a post-earnings revaluation.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The SPY is seeing a massive, broad-based rally as market participants react to geopolitical headlines and Trump's comments regarding potential negotiations, fueling a surge that is squeezing out short sellers. While bulls are celebrating the rapid V-shaped recovery toward all-time highs, the community remains deeply divided, with many traders questioning the legitimacy of the move due to perceived low volume and market manipulation.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca is trending as it officially moves its stock listing to the New York Stock Exchange, a strategic transition supported by significant investment plans in the U.S. market. Additionally, the company is drawing attention due to reports of a potential multibillion-dollar acquisition of the French biotech firm Abivax, signaling an aggressive push to expand its pipeline and strengthen its global oncology and inflammation portfolio.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is trending as investors rally around the company's oncology platform, specifically focusing on the potential of Alpha DaRT technology in combination with checkpoint inhibitors like Keytruda. The community is actively discussing upcoming podium presentations and trial readouts, with many highlighting the stock as a long-term play fueled by strong clinical foundations and institutional interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
